- Ceribell (CBLL, Financial) to announce Q1 2025 financial results after market close on May 8, 2025.
- A conference call will be held at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results.
- Webcast of the conference will be available live and archived in the Investor Relations section of the Ceribell website.
Ceribell, Inc. (CBLL), a medical technology company focused on the diagnosis and management of serious neurological conditions, has scheduled the release of its financial results for the first quarter of 2025 on May 8, 2025, after the market closes. The announcement will be followed by a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial performance and outlook.
Interested investors can participate in the conference call by dialing (800) 715-9871 for domestic calls or (646) 307-1963 for international calls, using the access code 7370458. In addition, a live and archived webcast of the conference will be available in the "Investor Relations" section on the Ceribell website at https://investors.ceribell.com/.
Ceribell is renowned for its Ceribell System, a point-of-care EEG platform enhanced by AI-powered algorithms, enabling rapid diagnosis and continuous monitoring for patients with neurological conditions. The system is FDA 510(k) cleared for indicating suspected seizure activity and is actively used in various intensive care units and emergency rooms across the United States.
